Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
9/20/2022
Immuno Cure BioTech Acquires Shanghai Teresa Healthcare
9/20/2022
SCMP: Biden's Biotech Plan Has Limited Near-Term Impact on Chinese Fir...
9/19/2022
NHSA Announces the List of Drugs Passing Preliminary Form Evaluation f...
9/19/2022
CDE Solicits Comments on the Draft Technical Guidelines of Quantitativ...
9/16/2022
METiS Enters License Agreement with Voronoi for Pan-RAF Inhibitor
9/16/2022
Top Ten Listed Chinese Medpharm Cos by R&D Investment in H1/2022
9/16/2022
MOFCOM: Review of Pharmaceutical Distribution Industry Performance in ...
9/16/2022
Competition Intensifies as More Chinese Regions Embarks on Free HPV Va...
9/16/2022
Recent Executive Moves
9/16/2022
Drug R&D and Product Registration News Digest September 2022 (2)
9/16/2022
Chinese Pharma Companies Raised Over $500M in August (PharmaDJ)
9/16/2022
Junshi Biosciences Hits Revenue Roadblock Amid Covid Drug Delay (The B...
9/16/2022
Biotech May Be the Next U.S.-China Battleground (WSJ)
9/15/2022
CDE Solicits Comments on the Draft Technical Guidelines for Clinical R...
9/14/2022
CDE Issues the List of Reference Formulations for GQCE Studies (58th B...
9/14/2022
MIIT: China to Further Optimize Industrial Chain for Pharmaceutical Se...
9/14/2022
China Pushes for Mutual Recognition of Drug Regulations at SCO Forum
9/14/2022
Antengene Opens New Office in Australia as It Takes On Four Trials in ...
9/14/2022
Henlius to Spearhead Global Plans through Partnerships in Emerging Mar...
9/12/2022
WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility t...
9/12/2022
HitGen's Vernalis Research and Unison Medicines Enter Research Partne...
9/12/2022
Cellusion and Fosun's Celregen Enter License Pact over CLS001 for a Co...
9/12/2022
CFIUS Derails Asymchem's Acquisition of Snapdragon
9/12/2022
Biden Signs Executive Order to Boost US Biotechnology and Cut Relian...
9/9/2022
CDE Solicits Comments on Draft Technical Guidelines for Continuous Man...
9/9/2022
CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines Q3D(...
9/9/2022
Recent Executive Moves
9/7/2022
Neovii and Fosun Enter into an Licesing Pact for Grafalon in Greater C...
9/7/2022
Vision Forward Remains Blurry for Chinese Economy and Healthcare Secto...
9/7/2022
In China, Real-World Evidence Is Playing An Increasingly Important Rol...
Page:
127
/
774
Total number of articles:
23207
:
[First]
[<<]
[125]
[126]
[127]
[128]
[129]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit